Company records / arobiotx.com

Aro Biotherapeutics

Aro Biotherapeutics (arobiotx.com): no confident changes recorded yet; website history since August 2020. Homepage last checked 6 November 2026.

First recorded website

Observed 4 August 2020

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Aro Biotherapeutics - Philadelphia | Centyrins to Treat Cancer

Aro Biotherapeutics is focused on the development of a new protein drug platform called Centyrins, designed to achieve better efficacy and safety profiles for patients with cancer and other serious di

archived page Link to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

No changes recorded yet. Missing observations do not mean the company has not changed.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

July 2021 – November 2026 · 10 captures · latest observed messagingCREATING A NEW CLASS OF TARGETED MEDICINES
Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.
This wording observed 6 November 2026.
current websiteHistorical capture not publicly available
Inspect 10 captures in this group
- 29 July 2021 · CREATING A NEW CLASS OF RECEPTOR TARGETED GENETIC MEDICINES archived page
- 3 July 2022 · CREATING A NEW CLASS OF RECEPTOR TARGETED GENETIC MEDICINES archived page
- 5 January 2023 · CREATING A NEW CLASS OF RECEPTOR TARGETED GENETIC MEDICINES archived page
- 4 January 2024 · CREATING A NEW CLASS OF RECEPTOR TARGETED GENETIC MEDICINES archived page
- 1 January 2025 · CREATING A NEW CLASS OF RECEPTOR TARGETED GENETIC MEDICINES archived page
- 9 July 2025 · CREATING A NEW CLASS OF RECEPTOR TARGETED GENETIC MEDICINES archived page
- 16 June 2026 · CREATING A NEW CLASS OF TARGETED MEDICINES archived page
- 30 September 2026 · CREATING A NEW CLASS OF TARGETED MEDICINES archived page
- 12 October 2026 · CREATING A NEW CLASS OF TARGETED MEDICINES archived page
- 6 November 2026 · CREATING A NEW CLASS OF TARGETED MEDICINES current websiteHistorical capture not publicly available
Seen August 2020 · 1 captureAro Biotherapeutics - Philadelphia | Centyrins to Treat Cancer
Aro Biotherapeutics is focused on the development of a new protein drug platform called Centyrins, designed to achieve better efficacy and safety profiles for patients with cancer and other serious di
This wording observed 4 August 2020.
archived page

Cite this record

StartupHistory, “Aro Biotherapeutics” company record, https://startuphistory.org/c/arobiotx.com

Machine-readable: /c/arobiotx.com.json. How changes are found: method.